Breast Cancer Clinical Trials in Washington

Showing 121-140 of 175 trials

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

NCT00394082

The purpose of this study is to evaluate the safety and tolerability of weekly ABI-007 in combination with bevacizumab. The evaluation of progression-free survival of weekly ABI-007 in combination with bevacizumab for patients with previously untreated advanced/metastatic breast cancer.

Metastatic Breast Cancer

Celgene50 participantsStarted Jun 2006

Melbourne, Florida, United States • Ocoee, Florida, United States • Niles, Illinois, United States +17 more locations

COMPLETEDNA42 miles

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

NCT01720602

This pilot clinical trial studies vorinostat in treating patients with stage IV breast cancer receiving hormone therapy. Vorinostat may help hormone therapy work better by making tumor cells more sensitive to the drug.

Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer

University of Washington15 participantsStarted Nov 2012

Seattle, Washington, United States

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

Breast Cancer Trials in Other Cities

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

Clinical Trial of Trametes Versicolor in Women With Breast Cancer

A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi

Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer

The Prone Breast Radiation Therapy Trial

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg

NOLAN: Naproxen or Loratadine and Neulasta

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

MRI to Detect Breast Tumors in Women

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

Other Conditions in Washington